Different cytogenetic subgroups of AML have distinct DNA methylation profiles [171], and DNA methylation signatures could sub-stratify large genetic groups, such as NPM1-mutated AML, possibly identifying new prognostically relevant disease entities [171,172]. This evidence concerns the gene NPM1 and acute myeloid leukemia.